Gold nanoparticles (GNPs) emerged as promising antitumor radiosensitizers. However, the complex dependence of GNPs radiosensitization on the irradiation conditions remains unclear. In the present study, we investigated the impacts of the dose rate and photon energy on damage of the pBR322 plasmid DNA exposed to X-rays in the presence of 12 nm, 15 nm, 21 nm, and 26 nm GNPs. The greatest radiosensitization was observed for 26 nm GNPs. The sensitizer enhancement ratio (SER) 2.74 ± 0.61 was observed at 200 kVp with 2.4 mg/mL GNPs. Reduction of X-ray tube voltage to 150 and 100 kVp led to a smaller effect. We demonstrate for the first time that the change of the dose rate differentially influences on radiosensitization by GNPs of various sizes. For 12 nm, an increase in the dose rate from 0.2 to 2.1 Gy/min led to a ~1.13-fold increase in radiosensitization. No differences in the effect of 15 nm GNPs was found within the 0.85–2.1 Gy/min range. For 21 nm and 26 nm GNPs, an enhanced radiosensitization was observed along with the decreased dose rate from 2.1 to 0.2 Gy/min. Thus, GNPs are an effective tool for increasing the efficacy of orthovoltage X-ray exposure. However, careful selection of irradiation conditions is a key prerequisite for optimal radiosensitization efficacy.

This article discusses the design and analysis of a new chemical chemosensor for detecting mercury(II) ions. The chemosensor is a hydrazone made from 4-methylthiazole-5-carbaldehyde and fluorescein hydrazide. The structure of the chemosensor was confirmed using various methods, including nuclear magnetic resonance spectroscopy, infrared spectroscopy with Fourier transformation, mass spectroscopy, and quantum chemical calculations. The sensor’s ability in the highly selective and sensitive discovery of Hg²⁺ ions in water was demonstrated. The detection limit for mercury(II) ions was determined to be 0.23 µM. The new chemosensor was also used to detect Hg²⁺ ions in real samples and living cells using fluorescence spectroscopy. Chemosensor 1 and its complex with Hg²⁺ demonstrate a significant tendency to enter and accumulate in cells even at very low concentrations.

Simple procedures for Ta₂O₅ nanoparticle (NP) synthesis and surfactant-free stable hydrosol preparation were developed in order to investigate the colloidal properties, cytotoxicity, and CT contrast performance of uncoated Ta₂O₅ NPs.

Nanoparticle (NP) assisted magnetic hyperthermia (NMH) is a clinically proven method for cancer treatment. High-Z magnetic NPs could also be a perspective object for combining hyperthermia with tumor radiosensitization. However, this application of NPs is little studied, and it is unclear as to what particle compositions one can rely on. Therefore, the present work focuses on the search of materials that combine alternating magnetic field induced heating and high atomic number related dose enhancement abilities. A theoretical evaluation of 24 promising NP compositions was performed: the values of dose enhancement factor (DEF) were determined for kilovoltage x-ray spectra (30–300 kVp), as well as specific absorption rate (SAR) values were calculated for various combinations of elemental compositions and particle size distributions. For the alternating magnetic fields with amplitude $75\text{–}200\mathrm{Oe}$ and frequency $100\mathrm{kHz}$ , the maximum obtained SAR values ranged from 0.35 to $6000\mathrm{W}{\mathrm{g}}^{-1}$ , while DEF values for studied compounds ranged from 1.07 to 1.59. The increase in the monodispersity of NPs led to a higher SAR, confirming well-known experimental data. The four types of SAR dependences on external magnetic field amplitude and anisotropy constant were found for various particle sizes. The most predictable SAR behavior corresponds to larger NPs (∼70–100 nm). Thus, based on these calculations, the most promising for the combination of NMH with radiotherapy, from a physical point of view, are $\mathrm{L}{\mathrm{a}}_{0.75}\mathrm{S}{\mathrm{r}}_{0.25}\mathrm{Mn}{\mathrm{O}}_3$ , $\mathrm{G}{\mathrm{d}}_5\mathrm{S}{\mathrm{i}}_4$ , $\mathrm{SmC}{\mathrm{o}}_5$ , and $\mathrm{F}{\mathrm{e}}_{50}\mathrm{R}{\mathrm{h}}_{50}$ . The greatest dose enhancement is expected for superficial radiotherapy (in the voltage range up to ∼60 kVp).